Structural basis of BMP signalling inhibition by the cystine knot protein Noggin

被引:429
作者
Groppe, J
Greenwald, J
Wiater, E
Rodriguez-Leon, J
Economides, AN
Kwiatkowski, W
Affolter, M
Vale, WW
Belmonte, JCI
Choe, S
机构
[1] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA
[3] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA
[4] Inst Gulbenkian Ciencias, P-2780901 Oeiras, Portugal
[5] Biozentrum, CH-4056 Basel, Switzerland
[6] Regeneron Pharmaceut Inc, New York, NY 10591 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
D O I
10.1038/nature01245
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interplay between bone morphogenetic proteins (BMPs) and their antagonists governs developmental and cellular processes as diverse as establishment of the embryonic dorsal-ventral axis, induction of neural tissue, formation of joints in the skeletal system and neurogenesis in the adult brain. So far, the three-dimensional structures of BMP antagonists and the structural basis for inactivation have remained unknown. Here we report the crystal structure of the antagonist Noggin bound to BMP-7, which shows that Noggin inhibits BMP signalling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors. The BMP-7-binding affinity of site-specific variants of Noggin is correlated with alterations in bone formation and apoptosis in chick limb development, showing that Noggin functions by sequestering its ligand in an inactive complex. The scaffold of Noggin contains a cystine (the oxidized form of cysteine) knot topology similar to that of BMPs; thus, ligand and antagonist seem to have evolved from a common ancestral gene.
引用
收藏
页码:636 / 642
页数:7
相关论文
共 51 条
  • [1] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [2] Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
    Brunet, LJ
    McMahon, JA
    McMahon, AP
    Harland, RM
    [J]. SCIENCE, 1998, 280 (5368) : 1455 - 1457
  • [3] Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin
    Capdevila, J
    Tsukui, T
    Esteban, CR
    Zappavigna, V
    Belmonte, JCI
    [J]. MOLECULAR CELL, 1999, 4 (05) : 839 - 849
  • [4] Endogenous and ectopic expression of noggin suggests a conserved mechanism for regulation of BMP function during limb and somite patterning
    Capdevila, J
    Johnson, RL
    [J]. DEVELOPMENTAL BIOLOGY, 1998, 197 (02) : 205 - 217
  • [5] Novel approach to phasing proteins: derivatization by short cryo-soaking with halides
    Dauter, Z
    Dauter, M
    Rajashankar, KR
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 : 232 - 237
  • [6] Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism
    Dixon, ME
    Armstrong, P
    Stevens, DB
    Bamshad, M
    [J]. GENETICS IN MEDICINE, 2001, 3 (05) : 349 - 353
  • [7] Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb
    Duprez, D
    Bella, EJD
    Richardson, MK
    Archer, CW
    Wolpert, L
    Brickell, PM
    FrancisWest, PH
    [J]. MECHANISMS OF DEVELOPMENT, 1996, 57 (02) : 145 - 157
  • [8] ECONOMIDES AN, 2000, Patent No. 6075007
  • [9] Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes
    Enomoto-Iwamoto, M
    Iwamoto, M
    Mukudai, Y
    Kawakami, Y
    Nohno, T
    Higuchi, Y
    Takemoto, S
    Ohuchi, H
    Noji, S
    Kurisu, K
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 140 (02) : 409 - 418
  • [10] BMP/GDF-signalling interactions during synovial joint development
    Francis-West, PH
    Parish, J
    Lee, K
    Archer, CW
    [J]. CELL AND TISSUE RESEARCH, 1999, 296 (01) : 111 - 119